About ProSomnus
ProSomnus is a publicly listed company based in Dublin (United States) founded in 2016. Lower jaw advancement devices for obstructive sleep apnea are developed. ProSomnus has raised $12.68 million across 6 funding rounds from investors including Spring Mountain Capital, Cetuscapitalpartners and HealthpointCapital. Its website prosomnus.com draws about 27 thousand monthly visits. ProSomnus offers products and services including ProSomnus Device and Home Sleep Test. Its focus areas include Life Sciences, Sleep Medicine, Medical Device and Therapeutics. Its legal entity is ProSomnus Sleep Technologies. Its competitors include ResMed, AeroCare Holdings and Sommetrics; 2 of its 3 listed competitors have raised funding.
Company details
Technologies for sleep and snoring management in dental care are developed by ProSomnus, founded in 2016 and based in Dublin, United States. The MicrO2 device is designed to advance the lower jaw forward, thereby alleviating snoring and obstructive sleep apnea symptoms by repositioning throat tissues. Tongue space is provided, allowing the mouth to open and close during use. Operations focus on dental settings for patient treatment.
- Total Equity Funding$12.68M (USD)
in 6 rounds
- Latest Funding Round$38M (USD), Post-IPO
Feb 2026
- InvestorsSpring Mountain Capital
& 3 more
Products & Services of ProSomnus
ProSomnus offers a comprehensive portfolio of products and services, including ProSomnus Device and Home Sleep Test.
Oral appliance that holds jaw forward to treat sleep apnea and snoring.
Convenient test to detect sleep apnea for patients at home.
Apps and channels of ProSomnus
its YouTube channel ProSomnus Marketing has 217 subscribers and 30 videos.
Videos from ProSomnus
The most watched videos on ProSomnus's YouTube channel, ProSomnus Marketing (217 subscribers). Click a video to play it here.
More on ProSomnus Marketing.
Funding Insights of ProSomnus
ProSomnus has successfully raised a total of $12.68M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $38 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.68M
- Total Rounds 6
- Last Round Post-IPO — $38M
- Investors Count 4
All 6 funding rounds of ProSomnus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2026 | $38M | Post-IPO | – | – | |
| Sep 2023 | $10.13M | Post-IPO | – | – | |
| Aug 2019 | $50,000 | Debt – Conventional | – | – | – |
| May 2019 | $3.5M | Series A | – | – | – |
| May 2017 | $9.18M | Series A | – | – | – |
| Oct 2016 | Seed | – | – |
4 investors in total: 4 institutional.
Investors in ProSomnus
ProSomnus has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Spring Mountain Capital, Cetuscapitalpartners and HealthpointCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on multiple sectors | smcgrowthcapital.com | New York, United States | ||
HealthpointCapital is focused on private equity in musculoskeletal healthcare. | healthpointcapital.com | San Diego, United States | ||
| cataliocapital.com | ||||
| cetuscapitalpartners.com |
Investor details for ProSomnus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ProSomnus
14 people are tracked at ProSomnus (9 in leadership, 5 in board & advisors).
| Name | Role | Group |
|---|---|---|
Edward T. Sall | Medical Director | Leadership |
Sung Kim | Co-Founder & CTO | Leadership |
Len Liptak | Co-Founder & CEO | Leadership |
John E. Remmers | Chief Scientist | Leadership |
Brian Dow | Chief Financial Officer | Leadership |
Jerry Vogel | VP, Strategic Partnerships | Leadership |
Divya Mavalli | Vice President, Regulatory & Quality | Leadership |
Heather Whalen | VP, Marketing Communications | Leadership |
Gregory Vogel | Associate VP, International Business | Leadership |
Shouresh Charkhandeh | Global Scientific Committee Chair | Board & advisors |
Len Hedge | Director | Board & advisors |
Jason Orchard | Director | Board & advisors |
Bill Johnson | Director | Board & advisors |
Steven Pacelli | Director | Board & advisors |
Complete people profiles for ProSomnus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ProSomnus
4 dated milestones of ProSomnus across 10 years, from founding to its latest funding, stage changes and deals.
- Founded ProSomnus is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $38.0M.
Competitors of ProSomnus
ProSomnus has 3 listed competitors in our database, 2 of them funded. They include ResMed, AeroCare Holdings and Sommetrics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| resmed.com | 1989 | San Diego, United States | 9,980 | Therapeutic devices to treat sleep apnea and respiratory disorders | ||
| aerocareusa.com | 2002 | Orlando, United States | $1M | 2,688 | Provider of medical devices for obstructive respiratory diseases and sleep apnea | |
| sommetrics.com | 2007 | San Diego, United States | $31.1M | 16 | Sommetrics is focused on diagnosing, treating and monitoring Obstructive Sleep Effect. |
Detailed competitors of ProSomnus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProSomnus
The website of ProSomnus (prosomnus.com) receives about 27.2K visits a month and ranks #1,129,210 among all websites worldwide, #1,149 in Dentist and Dental Services.
- Monthly visits27.2K
▲ 34.9% vs previous month
- Unique visitors5.6K
per month
- Global rank#1,129,210
among all websites
- Category rank#1,149
Health · Dentist and Dental Services
- Bounce rate34%
- Pages per visit3.3
- Average visit3 min 30 sec
- DevicesDesktop 77% · Mobile 23%
Websites whose visitors overlap most with ProSomnus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nsmedicaldevices.com | nsmedicaldevices.com | 100% | #2,151,615 | – |
Top companies in Sleep Medicine
3 companies that operate in the same segment as ProSomnus (Sleep Medicine) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic devices to treat sleep apnea and respiratory disorders | 1989 | San Diego, California, United States | USD 5.65 B | 10,600 | ||
Smart baby monitors and sleep tracking solutions are provided. | 2014 | New York, New York, United States | USD 116.6 M | |||
Devices and apps for snoring and sleep-disordered breathing are provided. | 2015 | Needham, Massachusetts, United States | USD 57.15 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Prosomnus
Complete news archive for ProSomnus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProSomnus
ProSomnus was founded in 2016.
ProSomnus is headquartered in Dublin, United States.
ProSomnus is a funded company, having raised a total of $12.68M across 6 funding rounds to date.
Technologies for sleep and snoring management in dental care are developed by ProSomnus, founded in 2016 and based in Dublin, United States. The MicrO2 device is designed to advance the lower jaw forward, thereby alleviating snoring and obstructive sleep apnea symptoms by repositioning throat tissues. Tongue space is provided, allowing the mouth to open and close during use. Operations focus on dental settings for patient treatment.
ProSomnus's top competitors include ResMed, AeroCare Holdings and Sommetrics.
ProSomnus offers ProSomnus Device and Home Sleep Test.
ProSomnus has 4 investors. Key investors include Spring Mountain Capital, Cetuscapitalpartners, HealthpointCapital, and Catalio Capital Management.
ProSomnus operates through Prosomnus Sleep Technologies.